These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 24019080)
1. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080 [TBL] [Abstract][Full Text] [Related]
2. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR; Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460 [TBL] [Abstract][Full Text] [Related]
3. Strategies for the prevention of postoperative recurrence of Crohn's disease. Yamamoto T; Watanabe T Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911 [TBL] [Abstract][Full Text] [Related]
4. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study. Papamichael K; Archavlis E; Lariou C; Mantzaris GJ J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843 [TBL] [Abstract][Full Text] [Related]
5. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease]. Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650 [TBL] [Abstract][Full Text] [Related]
6. Prevention of postoperative recurrence of Crohn's disease. van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096 [TBL] [Abstract][Full Text] [Related]
7. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Yamamoto T; Umegae S; Matsumoto K Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566 [TBL] [Abstract][Full Text] [Related]
8. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study. Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678 [TBL] [Abstract][Full Text] [Related]
9. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028 [TBL] [Abstract][Full Text] [Related]
10. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study]. Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease. Ford AC Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230 [No Abstract] [Full Text] [Related]
12. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease. Doherty GA; Miksad RA; Cheifetz AS; Moss AC Inflamm Bowel Dis; 2012 Sep; 18(9):1608-16. PubMed ID: 21905173 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response. Reinisch W; Stange EF; Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886 [No Abstract] [Full Text] [Related]
14. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence. Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G; J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532 [TBL] [Abstract][Full Text] [Related]
15. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504 [TBL] [Abstract][Full Text] [Related]
16. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Hanauer SB; Korelitz BI; Rutgeerts P; Peppercorn MA; Thisted RA; Cohen RD; Present DH Gastroenterology; 2004 Sep; 127(3):723-9. PubMed ID: 15362027 [TBL] [Abstract][Full Text] [Related]
17. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease. Cossu A; Biancone L; Ascolani M; Pallone F; Boirivant M J Crohns Colitis; 2013 Jul; 7(6):441-50. PubMed ID: 22840925 [TBL] [Abstract][Full Text] [Related]
18. Interventions for prevention of post-operative recurrence of Crohn's disease. Doherty G; Bennett G; Patil S; Cheifetz A; Moss AC Cochrane Database Syst Rev; 2009 Oct; (4):CD006873. PubMed ID: 19821389 [TBL] [Abstract][Full Text] [Related]
19. [Postoperative recurrence: adalimumab is an effective standard medication]. Hofmann-Aßmus M Z Gastroenterol; 2014 Mar; 52(3):260. PubMed ID: 24761446 [No Abstract] [Full Text] [Related]
20. Medical therapy to reduce postoperative Crohn's disease recurrence. Achkar JP; Hanauer SB Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]